Anna E. Marneth
Impact in
- Hematology top 5%
- Platelet Disorders and Treatments
- Acute Myeloid Leukemia Research
- Blood groups and transfusion
- Genetics top 10%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Blood disorders and treatments
Papers in
- Hematology 18
- Platelet Disorders and Treatments 8
- Acute Myeloid Leukemia Research 6
- Blood groups and transfusion 5
- Chronic Myeloid Leukemia Treatments 4
- Genetics 10
- Myeloproliferative Neoplasms: Diagnosis and Treatment 10
- Blood disorders and treatments 7
- Co-authors
- Bert A. van der Reijden (6 shared papers)Ann Mullally (9 shared papers)Joost H.A. Martens (3 shared papers)Tatyana Kuznetsova (1 shared paper)Hendrik G. Stunnenberg (1 shared paper)Koen H.M. Prange (1 shared paper)Ana M. Sotoca (1 shared paper)Olga Pozdnyakova (3 shared papers)
- Journals
- Haematologica (6 papers)Blood (5 papers)Leukemia (4 papers)Blood Advances (3 papers)HemaSphere (2 papers)
- Partner nations
- United StatesNetherlandsGermany
In The Last Decade
Anna E. Marneth
25 papers receiving 609 citations
Peers
Comparison fields: 5 of 57
- Hematology 362
- Genetics 151
- Nephrology 40
- Immunology 101
- Genetics 94
Countries citing papers authored by Anna E. Marneth
This map shows the geographic impact of Anna E. Marneth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna E. Marneth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna E. Marneth more than expected).
Fields of papers citing papers by Anna E. Marneth
This network shows the impact of papers produced by Anna E. Marneth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna E. Marneth. The network helps show where Anna E. Marneth may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna E. Marneth, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 134 | |
| 2 | 2017 | 103 | |
| 3 | 2017 | 83 | |
| 4 | 2022 | 72 | |
| 5 | 2017 | 29 | |
| 6 | 2018 | 25 | |
| 7 | 2022 | 23 | |
| 8 | 2019 | 20 | |
| 9 | 2022 | 18 | |
| 10 | 2018 | 16 | |
| 11 | 2022 | 14 | |
| 12 | 2023 | 13 | |
| 13 | 2020 | 11 | |
| 14 | 2021 | 10 | |
| 15 | 2013 | 10 | |
| 16 | 2018 | 10 | |
| 17 | 2017 | 5 | |
| 18 | 2025 | 5 | |
| 19 | 2020 | 4 | |
| 20 | 2024 | 4 |
About Anna E. Marneth
Anna E. Marneth is a scholar working on Hematology, Genetics, Immunology, Genetics and Nephrology, having authored 27 papers that have together received 615 indexed citations. Recurring topics across this work include Myeloproliferative Neoplasms: Diagnosis and Treatment (10 papers), Platelet Disorders and Treatments (8 papers), Blood disorders and treatments (7 papers), Acute Myeloid Leukemia Research (6 papers), Blood groups and transfusion (5 papers), Chronic Myeloid Leukemia Treatments (4 papers), Renal Diseases and Glomerulopathies (3 papers) and Protein Degradation and Inhibitors (3 papers). The work is most often cited by research in Hematology (362 citations), Genetics (151 citations), Nephrology (40 citations), Immunology (101 citations) and Genetics (94 citations). Anna E. Marneth has collaborated with scholars based in United States, Netherlands and Germany. Frequent co-authors include Bert A. van der Reijden, Ann Mullally, Joost H.A. Martens, Tatyana Kuznetsova, Hendrik G. Stunnenberg, Koen H.M. Prange, Ana M. Sotoca, Olga Pozdnyakova, Kai W. Wucherpfennig and Christina M. Tringides. Their work appears in journals such as Haematologica, Blood, Leukemia, Blood Advances and HemaSphere.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.